
Biolase has been bleeding cash and losing money this year. Annual Revenue is 43.35M and they reported a loss of 2.96M last year, however that was an improvement from a loss of 8.78M in 2008 and 8.97M in 2007. Revenue has been down from those two years.
In 3 years Biolase's stock has fallen from a high of 8/share to trading today at 0.80. Hopefully, this stock will rebound to its 2007 prices for large profits.